Page 2 - Les meilleurs Chimiothérapie contre la leucémie en Israël pour votre Chimiothérapie contre la leucémie - TOP 25 des médecins

Spécialisé(e) en oncologie et radiologie au Centre Médical Assuta.

• Expérimenté dans les protocoles de chimiothérapie pour la leucémie
• Combine l'expertise en oncologie et en radiologie
• Exerce dans un centre médical de premier plan

Médecin-chef du Centre d'oncologie de l'Assuta Medical Center – un chef de file dans les soins du cancer, avec un accent sur le traitement de la leucémie.

• Oncologue spécialisé(e) dans les protocoles de chimiothérapie
• Prend en charge les cas complexes de leucémie dans un centre médical de premier plan
• Dirige les programmes de traitement du Centre d'oncologie

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Spécialiste israélien de premier plan en immunothérapie du cancer du poumon – le Prof. Peled dirige l'Unité de cancérologie thoracique au Davidoff Cancer Center.

• Expert en médecine personnalisée et en immuno-oncologie
• Récipiendaire du prix MERIT de l'ASCO pour la recherche sur le cancer du poumon
• Président du Comité de détection précoce et de prévention de l'IASLC
• Formation de perfectionnement (Fellowship) à l'Université du Colorado à Denver